Deferred Revenue

$220.40M

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Deferred Revenue

Latest reported$220.40Mperiod endingJun 30, 2026

REGN Quarterly Deferred Revenue ($0.00 → $220.40M)

Quarterly deferred revenue

High-resolution chart · PNG

REGN deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Deferred Revenue — Quarterly (USD)
Period ending	Deferred Revenue (USD)
Jun 30, 2026	220,400,000
Mar 31, 2026	636,200,000
Dec 31, 2025	553,000,000
Sep 30, 2025	545,600,000
Jun 30, 2025	481,900,000
Mar 31, 2025	619,300,000
Dec 31, 2024	627,700,000
Sep 30, 2024	627,200,000
Jun 30, 2024	586,000,000
Mar 31, 2024	516,700,000
Dec 31, 2023	458,900,000
Sep 30, 2023	417,300,000
Jun 30, 2023	381,100,000
Mar 31, 2023	426,300,000
Dec 31, 2022	477,900,000
Sep 30, 2022	547,200,000
Jun 30, 2022	566,300,000
Mar 31, 2022	491,300,000
Dec 31, 2021	442,000,000
Sep 30, 2021	507,800,000
Jun 30, 2021	520,000,000
Mar 31, 2021	464,900,000
Dec 31, 2020	577,700,000
Sep 30, 2020	494,800,000
Jun 30, 2020	461,500,000
Mar 31, 2020	479,200,000
Dec 31, 2019	591,700,000
Sep 30, 2019	608,700,000
Jun 30, 2019	592,400,000
Mar 31, 2019	530,700,000
Dec 31, 2018	452,500,000
Sep 30, 2018	462,945,000
Jun 30, 2018	488,575,000
Mar 31, 2018	391,913,000
Dec 31, 2017	320,138,000
Sep 30, 2017	319,868,000
Jun 30, 2017	312,256,000
Mar 31, 2017	238,418,000
Dec 31, 2016	231,664,000
Sep 30, 2016	242,683,000
Jun 30, 2016	188,225,000
Mar 31, 2016	172,940,000
Dec 31, 2015	153,487,000
Sep 30, 2015	155,056,000
Jun 30, 2015	69,746,000
Mar 31, 2015	71,187,000
Dec 31, 2014	74,025,000
Sep 30, 2014	70,972,000
Jun 30, 2014	67,133,000
Mar 31, 2014	66,073,000
Dec 31, 2013	47,000,000
Sep 30, 2013	48,795,000
Jun 30, 2013	49,182,000
Mar 31, 2013	50,358,000
Dec 31, 2012	50,831,000
Sep 30, 2012	53,067,000
Jun 30, 2012	55,269,000
Mar 31, 2012	52,570,000
Dec 31, 2011	51,640,000
Sep 30, 2011	53,425,000
Jun 30, 2011	53,326,000
Mar 31, 2011	330,269,000
Dec 31, 2010	54,723,000
Sep 30, 2010	58,223,000
Jun 30, 2010	60,867,000
Mar 31, 2010	185,941,000
Dec 31, 2009	44,544,000
Sep 30, 2009	198,546,000
Jun 30, 2009	215,798,000
Mar 31, 2009	58,281,000
Dec 31, 2008	47,504,000
Sep 30, 2008	58,381,000
Jun 30, 2008	66,976,000
Mar 31, 2008	55,640,000
Dec 31, 2007	44,432,000
Sep 30, 2007	68,814,000
Jun 30, 2007	69,926,000
Mar 31, 2007	63,523,000
Dec 31, 2006	23,543,000
Sep 30, 2006	13,644,000
Jun 30, 2006	15,042,000
Mar 31, 2006	15,284,000
Dec 31, 2005	17,020,000
Sep 30, 2005	12,922,000
Jun 30, 2005	12,906,000
Mar 31, 2005	12,463,000
Dec 31, 2004	15,267,000
Sep 30, 2004	15,616,000
Jun 30, 2004	21,629,000
Mar 31, 2004	17,388,000
Dec 31, 2003	40,173,000
Sep 30, 2003	24,473,000
Jun 30, 2003	35,021,000
Mar 31, 2003	34,104,000
Dec 31, 2002	9,659,000
Sep 30, 2002	8,041,000
Jun 30, 2002	4,220,000
Mar 31, 2002	5,464,000
Dec 31, 2001	6,766,000
Sep 30, 2001	3,772,000